These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 8213896)
21. N-3 fatty acids do not prevent restenosis after coronary angioplasty: results from the CART study. Coronary Angioplasty Restenosis Trial. Johansen O; Brekke M; Seljeflot I; Abdelnoor M; Arnesen H J Am Coll Cardiol; 1999 May; 33(6):1619-26. PubMed ID: 10334433 [TBL] [Abstract][Full Text] [Related]
22. Therapeutic dissection after successful coronary balloon angioplasty: no influence on restenosis or on clinical outcome in 693 patients. The MERCATOR Study Group (Multicenter European Research Trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis). Hermans WR; Rensing BJ; Foley DP; Deckers JW; Rutsch W; Emanuelsson H; Danchin N; Wijns W; Chappuis F; Serruys PW J Am Coll Cardiol; 1992 Oct; 20(4):767-80. PubMed ID: 1388181 [TBL] [Abstract][Full Text] [Related]
23. [Restenosis and arterial remodelling after coronary angioplasty]. Jørgensen B; Forfang K Tidsskr Nor Laegeforen; 1996 Aug; 116(20):2460-3. PubMed ID: 8928109 [TBL] [Abstract][Full Text] [Related]
24. [Restenosis after percutaneous transluminal coronary angioplasty]. Aschermann M Cas Lek Cesk; 1990 Apr; 129(17):513-5. PubMed ID: 2350767 [TBL] [Abstract][Full Text] [Related]
25. Differences in restenosis propensity of devices for transluminal coronary intervention. A quantitative angiographic comparison of balloon angioplasty, directional atherectomy, stent implantation and excimer laser angioplasty. CARPORT, MERCATOR, MARCATOR, PARK, and BENESTENT Trial Groups. Foley DP; Melkert R; Umans VA; de Jaegere PP; Strikwerda S; de Feyter PJ; Serruys PW Eur Heart J; 1995 Oct; 16(10):1331-46. PubMed ID: 8746901 [TBL] [Abstract][Full Text] [Related]
26. Exercise echocardiography performed early and late after percutaneous transluminal coronary angioplasty for prediction of restenosis. Hoffmann R; Lethen H; Flachskampf FA; Hanrath P Eur Heart J; 1995 Dec; 16(12):1872-9. PubMed ID: 8682020 [TBL] [Abstract][Full Text] [Related]
27. Silent ischemia after percutaneous transluminal coronary angioplasty: incidence and prognostic significance. Pfisterer M; Rickenbacher P; Kiowski W; Müller-Brand J; Burkart F J Am Coll Cardiol; 1993 Nov; 22(5):1446-54. PubMed ID: 8227804 [TBL] [Abstract][Full Text] [Related]
28. Initial and subsequent angiographic outcome of percutaneous transluminal angioplasty performed on internal mammary artery grafts. Ishizaka N; Ishizaka Y; Ikari Y; Isshiki T; Tamura T; Suma H; Yamaguchi T Br Heart J; 1995 Dec; 74(6):615-9. PubMed ID: 8541165 [TBL] [Abstract][Full Text] [Related]
29. The mechanisms of coronary restenosis: insights from experimental models. Ferns GA; Avades TY Int J Exp Pathol; 2000 Apr; 81(2):63-88. PubMed ID: 10762439 [TBL] [Abstract][Full Text] [Related]
30. Influence of the methodology of percutaneous transluminal coronary angioplasty on restenosis. Douglas JS; King SB; Roubin GS Am J Cardiol; 1987 Jul; 60(3):29B-33B. PubMed ID: 2956837 [TBL] [Abstract][Full Text] [Related]
31. Coronary stenting or balloon angioplasty for chronic total coronary occlusions: the Taiwan experience (a single-center report). Fang CC; Jao YT; Chen Y; Wang SP Angiology; 2005; 56(5):525-37. PubMed ID: 16193191 [TBL] [Abstract][Full Text] [Related]